Emerging nations 'will push drug spending above $1trn'

Global spending on pharmaceuticals is expected to break through the $1trillion (£650bn) barrier over the next five years as demand from emerging economies surges, research shows.

Drug sales are expected to grow at between 5 and 8 per cent per year until 2014, taking the total spent to $1.1trn, according to IMS Health, a healthcare industry intelligence group.

Established drugs losing their patent protection in the developing world, combined with stronger demand from these countries, will push up sales by nearly $300bn a year, the group said.

"Patient demand for pharmaceuticals will remain robust, despite the ongoing effects of the downturn being felt in many parts of the world," said Murray Aitken, a senior vice-president at IMS Health. "In developed markets with publicly funding healthcare plans, pressure by payers to curb drug spending will only intensify, but that will be more than offset by the ongoing, rapid expansion of demand in the emerging markets".

IMS expects drug sales in developing nations to grow at between 14 and 17 per cent over the next five years, overshadowing Western markets that will expand at between just 3 and 6 per cent. Despite this surge in emerging economies, IMS Health predicts that the US will continue to be the world's biggest market for healthcare, with a spend of $390bn by 2014.

Forecasts of stronger growth will come as welcome relief to the giants of the pharmaceuticals industry. Companies such as GlaxoSmithKline and AstraZeneca have reported stiffer competition in recent years from makers of generic drugs, who increasingly have used the courts to challenge the patents owned by the majors.

By 2014, drugs whose sales currently total $142bn will face new competition from cheaper generics, according to IMS. In the US, six blockbuster drugs will lose their patent protection by 2012, including GSK's asthma treatment, Advair, and Pfizer's anti-cholesterol pill, Lipitor. GSK and AstraZeneca have ramped up their efforts in emerging markets. David Brennan, the chief executive of AstraZeneca, said recently: "There is no denying the scale of the opportunity these markets present but, like anything else in this industry, it takes a sound strategy and excellent execution." Yesterday, the company said: "Everyone points to population growth in emerging markets, but what is as important is the rising demand driven by increasing middle classes."

Despite the predictions of strong growth, 2010 will see a temporary slowdown. The global market is expected to expand by between 4 and 6 per cent this year – compared with 7 per cent growth last year, when the market was worth $837bn. In 2008, the industry grew by 4.8 per cent.

IMS Health said this year's falls would be triggered by tighter price controls imposed by European governments. It also predicted that certain therapy areas were likely to lead international growth. Its report added: "As pharmaceutical industry research and development programmes adjust to the broad availability of low-cost generic options in many chronic therapy areas, higher growth will occur in those therapy areas where there is significant, unmet clinical need."

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Tax Manager / Accountant

£35 - £50k DOE: Guru Careers: A Tax Manager / Accountant (ACA / CA / CTA) is n...

Ashdown Group: Contracts Executive - City of London

£35000 - £37000 per annum + benefits: Ashdown Group: Contracts Executive - Cit...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree Group have been well esta...

Recruitment Genius: Call Centre Debt Collector - Multiple Roles

£21000 per annum: Recruitment Genius: This is an exciting opportunity to join ...

Day In a Page

Giants Club: After wholesale butchery of Idi Amin's regime, Uganda’s giants flourish once again

Uganda's giants are flourishing once again

After the wholesale butchery of Idi Amin's regime, elephant populations are finally recovering
The London: After 350 years, the riddle of Britain's exploding fleet is finally solved

After 350 years, the riddle of Britain's exploding fleet is finally solved

Archaeologists will recover a crucial item from the wreck of the London which could help shed more light on what happened in the vessel's final seconds
Airbus has patented a jet that could fly from London to New York in one hour

Airbus has patented a jet that could fly from London to New York in one hour

The invention involves turbojets and ramjets - a type of jet engine - and a rocket motor
10 best sun creams for kids

10 best sun creams for kids

Protect delicate and sensitive skin with products specially formulated for little ones
Tate Sensorium: New exhibition at Tate Britain invites art lovers to taste, smell and hear art

Tate Sensorium

New exhibition at Tate Britain invites art lovers to taste, smell and hear art
Ashes 2015: Nice guy Steven Finn is making up for lost time – and quickly

Nice guy Finn is making up for lost time – and quickly

He was man-of-the-match in the third Test following his recall to the England side
Ashes 2015: Remember Ashton Agar? The No 11 that nearly toppled England

Remember Ashton Agar?

The No 11 that nearly toppled England
Turkey-Kurdish conflict: Obama's deal with Ankara is a betrayal of Syrian Kurds and may not even weaken Isis

US betrayal of old ally brings limited reward

Since the accord, the Turks have only waged war on Kurds while no US bomber has used Incirlik airbase, says Patrick Cockburn
VIPs gather for opening of second Suez Canal - but doubts linger over security

'A gift from Egypt to the rest of the world'

VIPs gather for opening of second Suez Canal - but is it really needed?
Jeremy Corbyn dresses abysmally. That's a great thing because it's genuine

Jeremy Corbyn dresses abysmally. That's a great thing because it's genuine

Fashion editor, Alexander Fury, applauds a man who clearly has more important things on his mind
The male menopause and intimations of mortality

Aches, pains and an inkling of mortality

So the male menopause is real, they say, but what would the Victorians, 'old' at 30, think of that, asks DJ Taylor
Man Booker Prize 2015: Anna Smaill - How can I possibly be on the list with these writers I have idolised?

'How can I possibly be on the list with these writers I have idolised?'

Man Booker Prize nominee Anna Smaill on the rise of Kiwi lit
Bettany Hughes interview: The historian on how Socrates would have solved Greece's problems

Bettany Hughes interview

The historian on how Socrates would have solved Greece's problems
Art of the state: Pyongyang propaganda posters to be exhibited in China

Art of the state

Pyongyang propaganda posters to be exhibited in China
Mildreds and Vanilla Black have given vegetarian food a makeover in new cookbooks

Vegetarian food gets a makeover

Long-time vegetarian Holly Williams tries to recreate some of the inventive recipes in Mildreds and Vanilla Black's new cookbooks